MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance

18 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space

15 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System

03 Nov 2022 06:00:02 By Nasdaq GlobeNewswire

Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board

31 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

25 Oct 2022 15:01:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

21 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System

18 Oct 2022 07:45:00 By Nasdaq GlobeNewswire

Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System

13 Oct 2022 08:15:00 By Nasdaq GlobeNewswire

Microbot Medical Enhances Strategic Focus on its Endovascular Solutions

11 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System

10 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

07 Oct 2022 07:36:43 By Nasdaq GlobeNewswire

Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment

04 Oct 2022 07:30:00 By Nasdaq GlobeNewswire

Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi

19 Sep 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal

15 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference

13 Sep 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System

12 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke

08 Sep 2022 06:00:01 By Nasdaq GlobeNewswire

Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System

06 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month

02 Sep 2022 06:00:00 By Nasdaq GlobeNewswire

Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons

18 Aug 2022 06:00:00 By Nasdaq GlobeNewswire